http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101381366-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
filingDate 2005-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fda079836fa745bdbd77800bfd27885
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04a0048f547419a64f1c3cd7f09eaebe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b93f296d240b1c49514a649aafc5d0f
publicationDate 2011-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101381366-B
titleOfInvention Benzimidazole derivatives and their pharmaceutical use
abstract The present invention relates to a compound represented by formula (I) or a salt thereof, wherein R 1 is a group represented by the formula wherein R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are each independently a hydrogen atom Or C 6-1 alkyl. The compounds of the present invention are useful as drugs for the prevention or treatment of circulatory diseases such as hypertension and the like and metabolic diseases such as diabetes and the like. or
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102351853-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102351853-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9233954-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105079815-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012097697-A1
priorityDate 2004-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0520423-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1452176-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467879025

Total number of triples: 42.